secwatch.observer — SEC 8-K summary
======================================

Issuer:     Aptevo Therapeutics Inc. (APVO)
CIK:        0001671584
Form:       8-K
Filed at:   2024-12-03T23:59:59+00:00
Accession:  0000950170-24-132855
Event type: other_material
Sentiment:  neutral
Materiality: 0.50
Item codes: 5.03, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Aptevo Therapeutics completes 1-for-37 reverse stock split effective December 3, 2024
--------------------------------------------------------------------------------

- Certificate of Amendment filed with Delaware; split effective at 5:01 p.m. ET on December 3, 2024.
- Every 37 pre-split shares combined into one share; par value unchanged; no fractional shares issued.
- Trading on Nasdaq Capital Market begins on split-adjusted basis December 4, 2024; new CUSIP 03835L 405.
- Proportionate adjustments made to stock options, RSUs, warrants, and equity plan reserves.
- Stockholders' percentage ownership unchanged except for fractional share cash payments.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1671584/000095017024132855/0000950170-24-132855-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1671584/000095017024132855/apvo-20241203.htm
  HTML page:      https://secwatch.observer/filing/0000950170-24-132855

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer